There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
-
Product Code
CS-T-96709
M.F.
C50H53D16N7O9
M.W.
928.22
Category
Stable Isotopes
Storage Condition
Refer MSDS for complete information.
IUPAC Name
Hydrolyzed Ombitasvir-d16
References
"Feld, J.J., et al.: New Eng. J. Med., 370, 1594 (2014); Lawitz, E., et al.: J. Hepatol., 57, 24 (2012); Afdhal, N., et al.: New England J. Med., 370, 1889 (2014)"
Synonyms
Hydrolyzed Ombitasvir-d16
Application Notes
"Hydrolyzed Ombitasvir-d16 is a labelled impurity of Ombitasvir (O633200), which is a pharmaceutical drug that is used in the treatment of hepatitis C virus in patients with HCV genotype 1 infection. Ombitasvir inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion."
Hazard Compound
Refer MSDS for complete information.
Overview
"Hydrolyzed Ombitasvir-d16 is a labelled impurity of Ombitasvir (O633200), which is a pharmaceutical drug that is used in the treatment of hepatitis C virus in patients with HCV genotype 1 infection. Ombitasvir inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion."
